Filing Details
- Accession Number:
- 0001127602-19-028597
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-17 17:36:06
- Reporting Period:
- 2019-09-13
- Accepted Time:
- 2019-09-17 17:36:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1062822 | Lexicon Pharmaceuticals Inc. | LXRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1053890 | Raymond Debbane | 8800 Technology Forest Place The Woodlands TX 77381 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-13 | 8,869 | $2.46 | 219,244 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-13 | 400 | $2.47 | 219,644 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 3,990 | $2.60 | 223,634 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 5,795 | $2.61 | 229,429 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 3,110 | $2.62 | 232,539 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 4,800 | $2.63 | 237,339 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 2,100 | $2.64 | 239,439 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 1,100 | $2.66 | 240,539 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 4,600 | $2.67 | 245,139 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 1,300 | $2.68 | 246,439 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 500 | $2.69 | 246,939 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 400 | $2.70 | 247,339 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 6,443 | $2.71 | 253,782 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 8,082 | $2.72 | 261,864 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 11,100 | $2.73 | 272,964 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 1,900 | $2.74 | 274,864 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 6,853 | $2.75 | 281,717 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 4,500 | $2.76 | 286,217 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 12,400 | $2.77 | 298,617 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 3,900 | $2.78 | 302,517 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 7,500 | $2.79 | 310,017 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-09-16 | 3,400 | $2.80 | 313,417 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,321,214 | Indirect | By Invus C.V. |
Billionaire Hedge Funds
